Trial Profile
A Double Blind, Polysomnographic, Three-Way Crossover Study to Compare the Efficacy of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2011
Price :
$35
*
At a glance
- Drugs IN 10 003 (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 02 May 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2010 New trial record